GRDN
Guardian Pharmacy Services, Inc.
42.40$
+3.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.7% | -40.5% | +236.6% | -107.4% | – | -21.4% | +13.6% | +41.3% | +22.8% | -82.5% | +395.3% | – | |
| – | +1.6% | +0.8% | +2.6% | +2.5% | +3.2% | +2.2% | +4.2% | +6.4% | -1.7% | +4.1% | -2.8% | – | |
| – | -209.8% | – | -104.6% | – | -97.2% | +14.6% | +12.0% | -2.0% | -75.2% | +72.3% | +57.5% | – | |
| – | – | -163.2% | – | -460.4% | – | – | – | – | -65.3% | -844.7% | – | – | |
| – | -35.3% | +33.6% | -17.4% | +68.2% | -12.2% | +29.0% | -25.8% | +20.9% | -18.8% | +18.7% | -8.0% | – | |
| – | -75.7% | +213.7% | +264.2% | -46.0% | -6.5% | -16.3% | +134.5% | -31.1% | -47.5% | -0.8% | -6.1% | – | |
| – | +53.1% | -28.7% | +133.0% | -25.9% | -97.6% | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | -100.0% | – | – | -100.0% | – | +4.3% | +0.0% | – | |
| – | – | – | – | – | +2,934.2% | -97.5% | +1.1% | +41.1% | -32.5% | +2.5% | -7.0% | – | |
| – | +30.8% | -57.6% | +160.3% | – | -207.4% | -94.5% | -20.7% | -27.5% | -50.6% | +179.3% | -65.7% | – | |
| – | – | -541.2% | – | +2,516.1% | -191.3% | – | -48.4% | +266.7% | +64.9% | -102.5% | – | – | |
| – | +11.8% | -57.9% | +425.7% | -128.0% | – | -34.2% | +33.1% | +46.9% | +32.3% | -96.6% | +2,336.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.